Home
COVID-19
COVID-19 Ongoing Studies
COVID-19 Data Access
Research
Brain Sciences
Cancer
Cardiovascular
Gut Health
Infection & Antimicrobial Resistance (AMR)
Immunology
Metabolic Medicine & Endocrinology
Surgery & Technology
Facilities
ITMAT (Institute of Translational Medicine & Therapeutics)
iCARE
Informatics & Biobanking
Molecular Phenomics
Genetics & Genomics
Imaging
Circulating Biomarker Lab
Secure Enclave
Imperial Clinical Trials Unit
Patient Experience Research Centre
Industry
Collaborations
Contract
Commercialisation
Patients & Public
Patient & Public Involvement and Engagement Strategy
Get Involved
Public Advisory Panel
Pipeline
Discovery Science
Joint Translation Fund
Training
Non-Medical Opportunities
Chain-Florey Fellowships & Lecturers
Clinical Academic Training Office
About Us
Acknowledgement
NIHR Imperial BRC Team
Contact Us
Newsletter Sign up
Clinical Trials Performance
News
Stories by Paul Craven
Event
Innovation
Partnership
Imperial Enterprise Week: seven inventions and the inventors behind them
Published on
21
st
March 2018
Therapeutic
Imperial receives approval to begin the world’s first trial of MDMA to treat alcohol addiction
Published on
27
th
October 2017
Partnership
Training
Research training awards for non-medics (2017/18)
Published on
11
th
October 2017
First in Human
Partnership
Therapeutic
Relief from menopausal symptoms
Published on
22
nd
September 2017
Diagnostic
Prevention
Precision nutrition: metabolic profiling of diet and disease risk
Published on
22
nd
September 2017
Next page »